Optum life sciences UK

Medicines and health technology adoption We support the appropriate adoption of medicines and health technologies by operating directly within everyday clinical workflows. Through our clinical systems and digital capabilities, we help translate evidence and guidance into consistent, safe and scalable clinical practice. Powered by real-world clinical data and delivered at the point of care, our capabilities support adoption across three key areas: In workflow clinical decision support Prompts, alerts and guidance are embedded directly within the clinical systems clinicians already use, supporting timely, evidence based decision making at the point of care. Relevant information is delivered in context, enabling informed choices without disrupting routine practice.

Guideline aligned therapy implementation We support the appropriate uptake of guideline recommended medicines and health technologies by enabling consistent implementation across clinical teams and care settings. This helps reduce unwarranted variation and supports more equitable adoption across populations. Proactive patient identification and pathway activation Using real-world clinical data, we support the identification of at risk or undertreated patients and support their timely entry into appropriate care pathways. This enables earlier intervention and more consistent, pathway led care aligned to evidence and best practice. Together, these capabilities help ensure medicines and health technologies move from approval to appropriate use — embedded within everyday clinical care.

Our impact includes: • Improved dosing accuracy in heart failure • Proactive

identification of Hep C risk cohorts

• Kidney failure risk prediction at scale • Accelerated AF

pathway optimisation and referrals

Explore the full brochure to find out more.

10

11